These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6664885)

  • 21. Malignant melanoma of the skin: prognostic value of histology in 89 cases.
    Williams WJ; Davies K; Jones WM; Roberts MM
    Br J Cancer; 1968 Sep; 22(3):452-60. PubMed ID: 5681005
    [No Abstract]   [Full Text] [Related]  

  • 22. A Retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 8. The Relative prognostic value of various clinical and histological features evaluated by Cox's regression model.
    Liestøl K; Larsen TE; Grude TH
    Acta Pathol Microbiol Immunol Scand A; 1982 Nov; 90(6):449-54. PubMed ID: 7164819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
    Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
    Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic importance of a second invasive primary melanoma according to tumour stage.
    Youlden DR; Baade PD; Aitken JF; Green AC; Khosrotehrani K
    Br J Dermatol; 2017 Dec; 177(6):e336-e337. PubMed ID: 28771669
    [No Abstract]   [Full Text] [Related]  

  • 25. Malignant melanoma of the skin. Changing clinical stage at presentation, 1955-1979.
    Hove LM; Akslen LA; Hartveit F
    Oncology; 1987; 44(3):156-8. PubMed ID: 3601317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma.
    Murali R; Hughes MT; Fitzgerald P; Thompson JF; Scolyer RA
    Ann Surg; 2009 Apr; 249(4):641-7. PubMed ID: 19300224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013.
    Landow SM; Gjelsvik A; Weinstock MA
    J Am Acad Dermatol; 2017 Feb; 76(2):258-263. PubMed ID: 27887797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Stage I malignant melanoma of the skin. Prognostic value of thickness and level (author's transl)].
    Palangié A; Lassau F; Moreau T; Noury-Duperrat G; Cottenot F
    Nouv Presse Med; 1981 Jun; 10(28):2337-41. PubMed ID: 7267338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
    Conic RRZ; Ko J; Damiani G; Funchain P; Knackstedt T; Vij A; Vidimos A; Gastman BR
    J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contemporary treatment of malignant melanoma.
    Cady B; Legg MA; Redfern AB
    Am J Surg; 1975 Apr; 129(4):472-82. PubMed ID: 1124847
    [No Abstract]   [Full Text] [Related]  

  • 31. [Malignant melanoma in life insurance--thickness or anatomic layer?].
    Müller WA; Erlanger M
    Versicherungsmedizin; 1994 Dec; 46(6):193-5. PubMed ID: 7825264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical treatment and survival from cutaneous malignant melanoma.
    Heenan PJ; Weeramanthri T; Holman CD; Armstrong BK
    Aust N Z J Surg; 1985 Jun; 55(3):229-34. PubMed ID: 3863576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
    Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
    Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Histopathologic classification of malignant melanoma of the skin. Retrospective study of 149 cases].
    Hauser C; Gloor F
    Schweiz Med Wochenschr; 1979 Feb; 109(5):152-7. PubMed ID: 441722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OPG, OPN, EGF and VEGF Levels at Individual Breslow Score Stages in Malignant Melanoma.
    Treskova I; Topolcan O; Windrichova J; Simanek V; Slouka D; Treska V; Kucera R
    Anticancer Res; 2018 Aug; 38(8):4907-4911. PubMed ID: 30061268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant melanoma prognostic factors 6: distant metastases and length of survival.
    Day CL; Lew RA
    J Dermatol Surg Oncol; 1984 Sep; 10(9):686-9. PubMed ID: 6480971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Morphological prognostic criteria in skin melanoma].
    Parshikova SM; Khasanov ShR
    Vopr Onkol; 1991; 37(3):283-8. PubMed ID: 2031322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based staging system for malignant melanoma: is new necessarily better?
    Baron JM; Abuzahra F
    Lancet; 2004 Jul 31-Aug 6; 364(9432):395-6. PubMed ID: 15288720
    [No Abstract]   [Full Text] [Related]  

  • 39. Characteristics of the primary lesion of malignant melanoma as a guide to prognosis and therapy.
    Kapelanski DP; Block GE; Kaufman M
    Ann Surg; 1979 Feb; 189(2):225-35. PubMed ID: 426555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.